Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Matinas BioPharma Holdings, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2028 | $120.09M | $120.09M - $120.09M | -$24.02M | $11.00 | 1 |
| Dec 2027 | $45.20M | $45.20M - $45.20M | -$9.04M | -$2.50 | 1 |
| Dec 2026 | $93.32M | $93.32M - $93.32M | -$18.66M | -$5.00 | 1 |
| Dec 2025 | $63.92M | $63.92M - $63.92M | -$12.78M | -$1.50 | 1 |
| Dec 2024 | $500.0K | $500.0K - $500.0K | -$100.0K | -$4.06 | 1 |
| Dec 2023 | $1.10M | $1.10M - $1.10M | -$658.8K | -$5.50 | 2 |
| Dec 2022 | $2.77M | $2.77M - $2.77M | -$1.66M | -$5.455 | 1 |
| Dec 2021 | $354.1K | $354.1K - $354.1K | -$212.4K | -$5.833 | 1 |
| Dec 2020 | $1.12M | $1.12M - $1.12M | -$670.5K | -$5.621 | 1 |
| Dec 2019 | $116.0K | $116.0K - $116.0K | -$69.6K | -$6.25 | 1 |
| Dec 2018 | $160.0K | $160.0K - $160.0K | -$96.0K | -$7.25 | 1 |
| Dec 2017 | $171.0K | $171.0K - $171.0K | -$102.6K | -$18.50 | 1 |